Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from SpecGx LLC with status Current. The shortage was first posted on 07/14/2023.
Shortage Details
- Status
- Current
- Company
- SpecGx LLC
- Package NDC
- 0406-5112-01
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)
- Initial Posting
- 07/14/2023
- Revised Date